Mohamed M. Hafez

3.1k total citations
99 papers, 2.5k citations indexed

About

Mohamed M. Hafez is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Mohamed M. Hafez has authored 99 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 18 papers in Epidemiology and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Mohamed M. Hafez's work include Liver Disease Diagnosis and Treatment (10 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Hepatitis C virus research (5 papers). Mohamed M. Hafez is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Chemotherapy-induced organ toxicity mitigation (6 papers) and Hepatitis C virus research (5 papers). Mohamed M. Hafez collaborates with scholars based in Egypt, Saudi Arabia and United States. Mohamed M. Hafez's co-authors include Othman A. Al‐Shabanah, Mohamed M. Sayed‐Ahmed, Zeinab Hassan, Abdel‐Rahman N. Zekri, Ali Alhoshani, Mahmoud N. Nagi, Abdulaziz M. Aleisa, Salim S. Al‐Rejaie, Naif O. Al‐Harbi and Mashan L. Abdullah and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Mohamed M. Hafez

96 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed M. Hafez Egypt 29 703 446 364 323 252 99 2.5k
Halagowder Devaraj India 31 1.2k 1.7× 256 0.6× 206 0.6× 321 1.0× 292 1.2× 108 2.8k
George Notas Greece 31 1.1k 1.5× 515 1.2× 307 0.8× 534 1.7× 453 1.8× 106 3.4k
Rong Wu China 27 991 1.4× 368 0.8× 105 0.3× 381 1.2× 253 1.0× 129 2.3k
Ki‐Baik Hahm South Korea 33 1.0k 1.5× 252 0.6× 252 0.7× 395 1.2× 367 1.5× 85 2.6k
Feifei Guo China 22 1.5k 2.2× 423 0.9× 118 0.3× 300 0.9× 261 1.0× 95 2.7k
Yuan‐Yen Chang Taiwan 29 746 1.1× 303 0.7× 180 0.5× 285 0.9× 150 0.6× 81 2.0k
Yali Li China 34 1.3k 1.9× 320 0.7× 432 1.2× 416 1.3× 422 1.7× 161 3.6k
Yueqiu Gao China 25 862 1.2× 799 1.8× 235 0.6× 295 0.9× 530 2.1× 125 2.5k
Xiaofeng Yu China 30 1.5k 2.2× 310 0.7× 257 0.7× 253 0.8× 182 0.7× 124 3.0k
Josef Ozer United States 18 961 1.4× 298 0.7× 181 0.5× 247 0.8× 202 0.8× 27 2.5k

Countries citing papers authored by Mohamed M. Hafez

Since Specialization
Citations

This map shows the geographic impact of Mohamed M. Hafez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed M. Hafez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed M. Hafez more than expected).

Fields of papers citing papers by Mohamed M. Hafez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed M. Hafez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed M. Hafez. The network helps show where Mohamed M. Hafez may publish in the future.

Co-authorship network of co-authors of Mohamed M. Hafez

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed M. Hafez. A scholar is included among the top collaborators of Mohamed M. Hafez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed M. Hafez. Mohamed M. Hafez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hassan, Zeinab, et al.. (2024). In Vitro Antiviral and Anticancer Effects of Tanacetum sinaicum Essential Oil on Human Cervical and Breast Cancer. Asian Pacific Journal of Cancer Prevention. 25(4). 1457–1471. 4 indexed citations
2.
Othman, Mohamed S., Fazal Rahim, Rafaqat Hussain, et al.. (2024). Investigation of novel benzimidazole-based indole/thiazole hybrids derivatives as effective anti-diabetics and anti-alzheimer's agents: Structure-activity relationship insight, in vitro and in silico approaches. Journal of Molecular Structure. 1312. 138592–138592. 15 indexed citations
3.
Raafat, Nermin, et al.. (2020). Gene polymorphisms of Patatin-like phospholipase domain containing 3 (PNPLA3), adiponectin, leptin in diabetic obese patients. PLoS ONE. 15(6). e0234465–e0234465. 4 indexed citations
4.
Hafez, Mohamed M., et al.. (2019). Association of Apelin Genetic Variants with Type Two Diabetes Mellitus in Egyptian Population. 2019(1). 1–5. 1 indexed citations
5.
Almutairi, Mashal M., Wael A. Alanazi, Musaad A. Alshammari, et al.. (2017). Neuro-protective effect of rutin against Cisplatin-induced neurotoxic rat model. BMC Complementary and Alternative Medicine. 17(1). 472–472. 69 indexed citations
6.
Alhoshani, Ali, Mohamed M. Hafez, Sufia Husain, et al.. (2017). Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats. BMC Nephrology. 18(1). 194–194. 91 indexed citations
7.
Nadeem, Ahmed, Naif O. Al‐Harbi, Mushtaq Ahmad Ansari, et al.. (2016). Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model. Biochemical Pharmacology. 124. 69–82. 55 indexed citations
8.
Hafez, Mohamed M., et al.. (2014). Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiomyopathic rat models. Journal of Clinical & Experimental Cardiology. 2 indexed citations
9.
Hafez, Mohamed M., et al.. (2012). MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention. 13(2). 591–598. 68 indexed citations
10.
Zekri, Abdel‐Rahman N., Abeer A. Bahnassy, Mohamed M. Hafez, et al.. (2011). Characterization of chronic HCV infection-induced apoptosis. PubMed. 10(1). 4–4. 21 indexed citations
11.
12.
Al‐Shabanah, Othman A., et al.. (2010). Doxorubicin Toxicity can be Ameliorated during Antioxidant L‐Carnitine Supplementation. Oxidative Medicine and Cellular Longevity. 3(6). 428–433. 69 indexed citations
13.
Sayed‐Ahmed, Mohamed M., Abdulaziz M. Aleisa, Salim S. Al‐Rejaie, et al.. (2010). Thymoquinone Attenuates Diethylnitrosamine Induction of Hepatic Carcinogenesis Through Antioxidant Signaling. Oxidative Medicine and Cellular Longevity. 3(4). 254–261. 137 indexed citations
14.
Zekri, Abdel‐Rahman N., et al.. (2007). Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies. Leukemia & lymphoma. 48(9). 1828–1834. 12 indexed citations
15.
Hsu, Stephen, Fei Huang, Mohamed M. Hafez, Sidney J. Winawer, & Eileen Friedman. (1994). Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.. PubMed. 5(3). 267–75. 74 indexed citations
16.
Hafez, Mohamed M., et al.. (1991). Immunogenetic Susceptibility for Post-Schistosomal Hepatic Fibrosis. American Journal of Tropical Medicine and Hygiene. 44(4). 424–433. 13 indexed citations
17.
18.
Hafez, Mohamed M., et al.. (1990). Immunogenetic study of the response to streptococcal carbohydrate antigen of the cell wall in rheumatic fever.. Annals of the Rheumatic Diseases. 49(9). 708–714. 11 indexed citations
19.
Hafez, Mohamed M. & Mark E. Costlow. (1989). Phosphatidylethanolamine turnover is an early event in the response of NB2 lymphoma cells to prolactin. Experimental Cell Research. 184(1). 37–43. 7 indexed citations
20.
Hafez, Mohamed M., et al.. (1985). The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma. International Journal of Cancer. 36(1). 19–22. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Halagowder Devaraj Breakdown of academic impact, for papers by George Notas Breakdown of academic impact, for papers by Rong Wu Breakdown of academic impact, for papers by Ki‐Baik Hahm Breakdown of academic impact, for papers by Feifei Guo Breakdown of academic impact, for papers by Yuan‐Yen Chang Breakdown of academic impact, for papers by Yali Li Breakdown of academic impact, for papers by Yueqiu Gao Breakdown of academic impact, for papers by Xiaofeng Yu Breakdown of academic impact, for papers by Josef Ozer
Rankless by CCL
2026